Autoimmune Conditions
-
A $10 million gift has enabled the launch of a center focusing on optic disc drusen, a poorly understood eye disease that can lead to visual impairment or even blindness.
-
Microbial loss, ulcerative colitis linked
Bacteria normally inhabiting healthy people’s intestines — and the anti-inflammatory metabolites these bacteria produce — are depleted in ulcerative colitis patients, a Stanford study shows.
-
Stanford-led teams nab top clinical research prizes
Winning studies were chosen by members of the Clinical Research Forum, a nonprofit foundation that promotes the understanding of clinical research and its impact on health and health care.
-
New incubator for life science innovation
A recently vacated building in Stanford Research Park will be the future home of a new life science incubator and lab suites. Located near campus, this incubator will serve as an anchor for a preeminent life science district.
-
Inflammation turns mutation deadly
A simple viral infection in the lungs of rats can become a lethal form of pulmonary hypertension if a common mutation is present, new Stanford research shows.
-
Success in rheumatoid arthritis trial
In a large trial led by a Stanford investigator, an experimental drug produced clinically meaningful improvements for rheumatoid arthritis patients unresponsive to existing treatments.
-
Possible drug target for cardiomyopathy
Stanford researchers have uncovered how a genetic mutation contributes to a heart disease known as familial dilated cardiomyopathy. Existing drugs correct the defect in heart cells grown in a petri dish, suggesting a new therapeutic target.
-
Chronic fatigue syndrome biomarker found
Stanford scientists devised a blood-based test that accurately identified people with chronic fatigue syndrome, a new study reports.
-
Drug reduces kidney failure in diabetics
Canagliflozin, a drug approved to lower glucose levels in diabetic patients, can slow the progression of kidney disease, according to a study co-authored by a Stanford Medicine researcher.
-
Possible ‘bubble boy’ disease therapy
In preclinical trials, Stanford scientists and their collaborators harnessed the gene-editing system CRISPR-Cas9 to replace the mutated gene underpinning the devastating immune disease.
-
Possible zinc strategy for diabetes
To treat diabetes directly, rather than manage its symptoms, doctors need a way to get drugs to cells that produce insulin. The key, Stanford researchers report, may be those cells’ affinity for zinc.
-
Glucose spikes seen in healthy people
A study out of Stanford in which blood sugar levels were continuously monitored reveals that even people who think they’re “healthy” should pay attention to what they eat.
- Aging & Geriatrics
- AI, Technology & Innovation
- Anesthesiology & Pain Management
- Animal Research
- Autoimmune Conditions
- Biochemistry
- Bioengineering
- Blood Disorders (Hematology)
- Cancer
- Cardiology
- Cellular & Molecular Biology
- Community Programs
- Data Sciences
- Dermatology
- Diabetes
- Diversity, Equity & Inclusion
- Drug Development
- Ear, Nose & Throat
- Emergency Medicine
- Endocrinology
- Environment & Sustainability
- Epidemiology & Population Health
- Ethics
- Genetics
- Global Health
- Health Policy
- Immunology
- Infectious Disease
- Internal Medicine
- Kidney Health (Nephrology)
- Lung Health
- Maternal Health
- Men's Health
- Microbiology
- Neurobiology
- Neurology & Neurosurgery
- Nutrition
- Obituaries
- Obstetrics & Gynecology
- Ophthalmology
- Orthopaedics
- Palliative Care
- Pathology
- Pediatrics
- Physiology
- Precision Health
- Preventive Medicine
- Primary Care
- Psychiatry & Mental Health
- Radiology
- Stanford Medicine
- Stem Cells
- Surgery
- Transplantation
- Urology
- Vaccines
- Wellness
- Women's Health